http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018143685-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d37c77fb29f7d93cd42f9b7bf10b0e48 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-31 |
filingDate | 2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c17f70bbfe2f7b18dcb7b08e2f985a90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c3cea87e386e1ca3b28cc164ab0632d |
publicationDate | 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2018143685-A1 |
titleOfInvention | Patch composition for reducing blood pressure |
abstract | The present invention relates to a patch composition for reducing blood pressure and, more particularly, to a patch composition comprising an agonist selected from the group consisting of an agonist of transient receptor potential cation channel subfamily V member 1 (TRPV1) and an agonist of transient receptor potential cation channel subfamily A member 1 (TRPA1) as an effective ingredient for reducing blood pressure, a patch coated with the patch composition, and a method of using the patch. Containing an agonist selected from the group consisting of an agonist of TRPV1 and an agonist of TRPA1, the patch composition of the present invention can stimulate C-fibers in the median nerve inside the wrist to effectively reduce blood pressure caused by hypertension. Because the above-mentioned effect can be elicited by contacting a patch composition with the skin, the use of the patch composition or patch of the present invention has the advantage of reducing a blood pressure very conveniently and safely, compared to preexisting oral drugs. In addition, capsaicin or mustard oil rather than expensive compounds can be used as the agonist, which enjoys the advantage of providing the patch at very inexpensive cost. |
priorityDate | 2017-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.